{
    "title": "Noxopharm spin-off Nyrada floats on ASX",
    "url": "https://www.dailymail.co.uk/wires/aap/article-7893411/Noxopharm-spin-Nyrada-floats-ASX.html",
    "date": "2020-01-16",
    "keywords": [
        "drug",
        "brain",
        "cent",
        "candidate",
        "company",
        "nyrada",
        "damage",
        "stroke",
        "injury",
        "research",
        "sydney",
        "noxopharm",
        "cholesterol",
        "market",
        "pcsk9",
        "inflammation",
        "biotech",
        "debut",
        "asx",
        "float",
        "year",
        "offering",
        "spinoff",
        "thursday",
        "price",
        "shareholding",
        "nononcology",
        "treatment",
        "disability",
        "executive",
        "companys",
        "roadshow",
        "story",
        "everyone",
        "somebody",
        "blood",
        "protein",
        "lowdensity",
        "place",
        "statin",
        "medication",
        "lipitor",
        "inhibitor",
        "professor",
        "housley",
        "condition",
        "excitotoxicity",
        "cause",
        "mr",
        "bonnar",
        "property",
        "way",
        "development",
        "phase",
        "safety",
        "toxicity",
        "trial",
        "end",
        "revenue",
        "stream",
        "future",
        "prospectus",
        "point",
        "partner",
        "pain"
    ],
    "category": [
        "wires",
        "aap"
    ]
}